Next Article in Journal
Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy
Previous Article in Journal
Weight Gain after Hormone Receptor-Positive Breast Cancer
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(6), 4104-4116; https://doi.org/10.3390/curroncol29060327
Action Date Notes Link
article html file updated 27 December 2025 16:19 CET Update https://www.mdpi.com/1718-7729/29/6/327/html
article html file updated 10 September 2025 17:53 CEST Update -
article html file updated 3 August 2022 03:42 CEST Update -
article html file updated 6 June 2022 12:00 CEST Update -
article html file updated 6 June 2022 12:00 CEST Original file -
article pdf uploaded. 6 June 2022 11:59 CEST Version of Record https://www.mdpi.com/1718-7729/29/6/327/pdf
article xml uploaded. 6 June 2022 11:59 CEST Update https://www.mdpi.com/1718-7729/29/6/327/xml
article xml file uploaded 6 June 2022 11:59 CEST Original file -
Back to TopTop